X
SNY icon

Xponance’s Sanofi SNY Stock Holding History

Xponance’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$219K Buy
+4,550
New +$212K ﹤0.01% 1430

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Xponance's SNY Position: Q1 2026 in Review

Xponance opened a new position in Sanofi (SNY) in Q1 2026: 4,550 shares worth $219K. The stake represents ﹤0.01% of the portfolio and ranks #1430 among its holdings.

737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Xponance held 4,550 shares of Sanofi worth $219K as of Q1 2026.
  • Sanofi was a new Xponance position in Q1 2026.
  • Sanofi made up ﹤0.01% of Xponance's portfolio in Q1 2026, its #1430 holding.
  • 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Xponance's 13F filing for Q1 2026, filed 13 May 2026.